Table 2. Morphometric data.

Group	BW (gm)	HW (gm)	LV volume (cm3)	AR volume (cm3)	AR/LV (%)
CON	300.4±15.9	1.56±0.15	0.706±0.110	0.423±0.093	59.6±6.9
IPOC	297.5±21.4	1.58±0.17	0.736±0.134	0.401±0.090	54.5±5.1
AMD+IPOC	293.3±16.9	1.53±0.16	0.769±0.084	0.470±0.065	61.5±8.4
AMD	291.9±11.9	1.51±0.12	0.742±0.098	0.458±0.062	61.7±3.3

Data expressed as mean±standard deviation. There were no significant differences among groups.

AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); AR = area at risk; BW = body weight; CON = untreated control hearts (n=12); CXCR4 = chemokine receptor type 4; HW = heart weight; IPOC = ischemic postconditioning (n=8); LV = left ventricle.